StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Charles River Laboratories International, Inc.
NYSE:CRL
Sector
Industries
Location
Market Cap
USD 7.76 B
Share Price
USD 158.04
Avg Daily Volume
1,537,950
Change (1 day)
-0.85%
Change (1 year)
-26.90%
Change (YTD)
-14.39%
Charles River Laboratories International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 29, 2025: USD 546.00 M
Charles River Laboratories International, Inc. EBITDA is USD 546.00 M for the Trailing 12 Months (TTM) ending March 29, 2025, a -45.89% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Charles River Laboratories International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 1.01 B, a -5.79% change year over year.
-
Charles River Laboratories International, Inc. EBITDA for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 1.07 B, a 23.13% change year over year.
-
Charles River Laboratories International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 26, 2022 was USD 869.79 M, a 11.11% change year over year.
-
Charles River Laboratories International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 27, 2021 was USD 782.82 M, a 33.81% change year over year.
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%